Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,248 | 3,384 | 3,824 | 3,788 | 5,778 |
| Marketable Securities | 4,963 | 5,120 | 5,190 | 5,000 | 5,000 |
| Receivables | 2,961 | 5,133 | 3,277 | 2,872 | 2,092 |
| Income taxes - deferred | 70 | 89 | 637 | 827 | 1,049 |
| TOTAL | $15,607 | $13,876 | $13,089 | $12,706 | $14,087 |
| Non-Current Assets | |||||
| Intangibles | 264 | 280 | 211 | 225 | 178 |
| Other Non-Current Assets | 4,234 | 4,234 | 4,541 | 4,555 | 4,488 |
| TOTAL | $4,498 | $4,515 | $4,752 | $4,781 | $4,666 |
| Total Assets | $20,105 | $18,390 | $17,841 | $17,487 | $18,753 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 766 | 513 | 680 | 660 | 2,281 |
| TOTAL | $1,283 | $725 | $920 | $1,094 | $2,858 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 106 | 134 | 161 | 253 | 345 |
| TOTAL | $190 | $207 | $225 | $242 | $259 |
| Total Liabilities | $1,473 | $932 | $1,144 | $1,335 | $3,117 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,347 | 6,355 | 6,392 | 6,332 | 6,347 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | 1,042 | -311 | -1,412 | -1,883 | -2,550 |
| Other shareholders' equity | -132 | 74 | 434 | -378 | -90 |
| TOTAL | $18,632 | $17,458 | $16,696 | $16,151 | $15,636 |
| Total Liabilities And Equity | $20,105 | $18,390 | $17,841 | $17,487 | $18,753 |